The National Cancer Institute (NCI) has renewed City of Hope’s core grant and
|City of Hope continues its sstatus as a Comprehensive Cancer Center.|
Comprehensive Cancer Center status.
The five-year renewal, which was granted after extensive review, will carry City of Hope through 2013, its centennial year.
“This is the third time the NCI has renewed our Comprehensive Cancer Center status, and it’s a reflection of the high standard of our research and patient care, as well as the growing role City of Hope is taking on in the health of our community,” said Theodore G.Krontiris, M.D., Ph.D., professor of molecular medicine and director emeritus of the Comprehensive Cancer Center, who led the push for renewal. “It is something that we should all take great pride in.”
According to the NCI, a Comprehensive Cancer Center demonstrates superior depth
and breadth of research activities in each of three major areas: laboratory, clinical and population-based research, with substantial transdisciplinary research that bridges these scientific areas. An NCI-designated Comprehensive Cancer Center also conducts professional and public education and dissemination of clinical and public health advances into the community it serves.
Today, 39 Comprehensive Cancer Centers across the nation have earned the NCI designation. They are characterized by strong organizational capabilities, institutional commitment and transdisciplinary, cancer-focused science, according to the NCI; they also must have experienced scientific and administrative leadership and state-of-the-art cancer research and patientcare facilities.
The NCI grant awards fund formal research programs that foster interactions between basic laboratory, clinical and population scientists, as well as access for investigators to shared services and technologies that are necessary to their research efforts, and other scientific infrastructure. Grant applications must undergo a competitive peer review process that evaluates and ranks applications according to merit.
“The entire City of Hope faculty and staff should celebrate this achievement,” said Michael A. Friedman, M.D., president and chief executive officer. “The renewal is another signal that we are well on our way toward achieving the goals of our strategic plan and standing as leaders in transformational research.”